Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study

By lvarez Claudio   Alonso-Muriel Isabel   Garca Gabriela   Crespo Juana   Bellver Jos   Simn Carlos   Pellicer Antonio  

Human Reproduction, Vol. 22, Iss. 12, 2007-12 ,pp. : 3210-3214

Oxford University Press

Access to resources Recommend Favorite

Intrauterine insemination catheters for assisted reproduction: a systematic review and meta-analysis

By Abou-Setta Ahmed M.   Mansour Ragaa T.   Al-Inany Hesham G.   Aboulghar Mona A.   Kamal Ahmed   Aboulghar Mohamed A.   Serour Gamal I.  

Human Reproduction, Vol. 21, Iss. 8, 2006-08 ,pp. : 1961-1967

Oxford University Press

Access to resources Recommend Favorite

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

By Ragni G.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2421-2425

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment

By Egbase P.E.  

Human Reproduction, Vol. 15, Iss. 10, 2000-10 ,pp. : 2082-2086

Oxford University Press

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite